Longitudinal identification of clinically distinct neurophenotypes in young children with fragile X syndrome
Jennifer L Bruno1, David Romano1, Paul Mazaika2
1Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305-5795; jenbruno@stanford.edu dromano@stanford.edu.
Insights
Fragile X syndrome (FXS) subgroups were identified using brain MRI scans. This neuroimaging approach revealed distinct developmental patterns, potentially aiding in personalized interventions for FXS patients.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- Fragile X syndrome (FXS), caused by FMR1 gene mutations, is a leading inherited cause of developmental disability.
- Varied cognitive, behavioral, and neurological phenotypes in FXS complicate outcome prediction and intervention planning.
- Identifying early biological markers is crucial for understanding FXS heterogeneity.
Purpose of the Study:
- To investigate early structural brain growth patterns in young boys with FXS.
- To identify distinct neuroanatomical subgroups within the FXS population using longitudinal MRI data.
- To explore the potential of topological data analysis (TDA) for defining clinically relevant subtypes.
Main Methods:
- Longitudinal T1-weighted anatomical MRI scans were acquired from 42 young boys with FXS at two time points (mean ages 2.89 and 4.91 years).
- Topological data analysis (TDA), an unsupervised machine learning technique, was applied to the MRI data to identify subgroups.
- Cognitive, adaptive functioning, and autism severity scores were compared between identified subgroups post hoc.
Main Results:
- TDA successfully identified two distinct subgroups based solely on longitudinal brain MRI data.
- One subgroup consistently demonstrated higher functioning across cognitive, adaptive, and autism severity measures at both time points.
- Significant differences (P < 0.05) were observed between the subgroups, indicating neuroanatomically distinct and clinically relevant phenotypes.
Conclusions:
- The study supports the existence of two longitudinally defined, neuroanatomically distinct phenotypes in boys with FXS.
- Early structural brain growth, analyzed by TDA, can serve as a marker for identifying clinically meaningful subgroups.
- This approach may enhance outcome prediction, guide targeted therapies for FXS, and potentially define subtypes in other neuropsychiatric disorders.
Abstract:
Fragile X syndrome (FXS), due to mutations of the FMR1 gene, is the most common known inherited cause of developmental disability. The cognitive, behavioral, and neurological phenotypes observed in affected individuals can vary considerably, making it difficult to predict outcomes and determine the need for interventions. We sought to examine early structural brain growth as a potential marker for identification of clinically meaningful subgroups. Participants included 42 very young boys with FXS who completed a T1-weighted anatomical MRI and cognitive/behavioral assessment at two longitudinal time points, with mean ages of 2.89 y and 4.91 y. Topological data analysis (TDA), an unsupervised approach to multivariate pattern analysis, was applied to the longitudinal anatomical data to identify coherent but heretofore unknown subgroups. TDA revealed two large subgroups within the study population based solely on longitudinal MRI data. Post hoc comparisons of cognition, adaptive functioning, and autism severity scores between these groups demonstrated that one group was consistently higher functioning on all measures at both time points, with pronounced and significant unidirectional differences (P < 0.05 for time point 1 and/or time point 2 for each measure). These results support the existence of two longitudinally defined, neuroanatomically distinct, and clinically relevant phenotypes among boys with FXS. If confirmed by additional analyses, such information may be used to predict outcomes and guide design of targeted therapies. Furthermore, TDA of longitudinal anatomical MRI data may represent a useful method for reliably and objectively defining subtypes within other neuropsychiatric disorders.
More Related Videos
11:10Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
10:58TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
Published on: December 28, 2010
